Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® With Reference Product— Lantus®: Study Protocol &Amp; Early Data Trends

Open Journal of Endocrine and Metabolic Diseases
doi 10.4236/ojemd.2018.88016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,


Related search